Angiotensin antibodies and focal segmental glomerulosclerosis

New England Journal of Medicine

Volumn 368, Issue 10, 2013, Pages 971-973

  Alachkar, Nada ^a   Gupta, Gaurav ^b   Montgomery, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; IMMUNOGLOBULIN; LOSARTAN; RITUXIMAB; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ABNORMAL LABORATORY RESULT; ADULT; ANTIBODY TITER; CASE REPORT; CLINICAL FEATURE; DESENSITIZATION; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GRAFT REJECTION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

EID: 84874718342     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1207233     Document Type: Letter

References (5)

1. Dragun D, Müller DN, Bräsen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005;352:558-69.
2. Nijenhuis T, Sloan AJ, Hoenderop JGJ, et al. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 2011;179:1719-32.
3. Zhou CC, Zhang Y, Irani RA, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008;14:855-62.
4. Riemekasten G, Philippe A, Näther M, et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 2011;70:530-6.
5. Reinsmoen NL, Lai CH, Heidecke H, et al. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 2010;90:1473-7.